COVID-19 Therapeutics: Improvise—Adapt—Learn
Open Access
- 9 September 2022
- journal article
- editorial
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (18) , 5312
Abstract
“In the midst of chaos, there is also opportunity”—Sun Tzu, The Art of WarKeywords
This publication has 10 references indexed in Scilit:
- Estimated Impact of the US COVID-19 Vaccination Campaign—Getting to 94% of Deaths PreventedJAMA Network Open, 2022
- Global impact of the first year of COVID-19 vaccination: a mathematical modelling studyThe Lancet Infectious Diseases, 2022
- Effect of Early Treatment with Ivermectin among Patients with Covid-19New England Journal of Medicine, 2022
- Identification and Development of Therapeutics for COVID-19mSystems, 2021
- Dexamethasone in Hospitalized Patients with Covid-19New England Journal of Medicine, 2021
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial ResultsNew England Journal of Medicine, 2021
- The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19The American Journal of Tropical Medicine and Hygiene, 2021
- Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19Journal of Hospital Medicine, 2020
- Big studies dim hopes for hydroxychloroquineScience, 2020
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or BothNew England Journal of Medicine, 2017